United Services Automobile Association Vanda Pharmaceuticals Inc. Transaction History

United Services Automobile Association

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$12.27 - $15.79 $178,454 - $229,649	-14,544 Closed	0 $0
Q2 2019 Aug 16, 2019	BUY	$13.37 - $18.85 $10,589 - $14,929	792 Added 5.76%	14,544 $205,000
Q1 2019 May 13, 2019	BUY	$17.59 - $31.05 $77,202 - $136,278	4,389 Added 46.88%	13,752 $253,000
Q4 2018 Feb 13, 2019	BUY	$18.97 - $31.47 $2,902 - $4,814	153 Added 1.66%	9,363 $245,000
Q3 2018 Nov 13, 2018	BUY	$18.25 - $23.0 $168,082 - $211,830	9,210 New	9,210 $211,000

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $286M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.